Article Details

Takeda drug for rare types of epilepsy misses goal in late-stage trial | BioPharma Dive

Retrieved on: 2024-06-17 22:10:51

Tags for this article:

Click the tags to see associated articles and topics

Takeda drug for rare types of epilepsy misses goal in late-stage trial | BioPharma Dive. View article details on hiswai:

Excerpt

Disappointing results in Dravet and Lennox-Gastaut syndrome sparked a drop in share value for Ovid Therapeutics, which had partnered on the drug ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo